A new Curtin University study has found that people diagnosed with sarcoma—a cancer disproportionately affecting teenagers and young adults—are being left without the resources they urgently need.

A research team at the Seville Biomedical Institute (IBis) has identified a new molecular mechanism that explains the high sensitivity of Ewing sarcoma (an aggressive bone cancer that mainly affects ...

Sarcoma originates in connective tissues, with soft tissue and bone sarcomas as primary categories, each having multiple subtypes. Staging considers tumor size, grade, and metastasis, guiding ...

Ewing sarcoma is a rare and serious diagnosis, largely impacting children. The disease only accounts for about 1% of all pediatric cancers in the U.S., with about 250 children diagnosed every year, ...

Dr. Arun Singh, the director of the UCLA sarcoma medical oncology program, sat down with Daily Bruin contributor Donya Hassanshahi during Sarcoma Awareness Month to discuss his role in managing ...

ASCO 2025 showcased breakthroughs in sarcoma treatment, emphasizing precision medicine, immunotherapy, and promising new therapies for rare cancers. In the sarcoma field, this year marked a notable ...

HONOLULU (KHON2) — July is National Sarcoma Awareness Month, a time to recognize the signs of this rare type of cancer that affects about 17,000 people in the U.S. every year. Sarcoma is a cancer that ...

Plasma-activated medium (PAM) shows tumor-fighting effects against the rare form of cancer known as synovial sarcoma, an Osaka Metropolitan University-led research team has found. Graduate School of ...

A recent analysis reveals that the incidence rates of soft tissue sarcomas - cancers in muscle, fat, blood vessels, nerves, and tendons - are lower in young U.S. active-duty military servicemen ...

Adaptimmune Therapeutics is prepping for another FDA submission after 42% of patients with sarcoma responded to the company's investigational cell therapy in a pivotal phase 2 trial. The primary ...

Sarcomas, a diverse group of malignancies, exhibit substantial heterogeneity in both biological behavior and microenvironment, influencing their response to immunotherapy. Although pembrolizumab is ...